|1||NCT02115282||Recruiting||Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic||
||600||All||18 Years and older (Adult, Senior)||NCT02115282||NCI-2014-00746
|March 29, 2014||January 14, 2021||April 16, 2014||January 15, 2018||
|2||NCT01674140||Recruiting||S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer||
||Other / NIH||
||1900||All||18 Years and older (Adult, Senior)||NCT01674140||S1207
|e3||April 2013||December 2022||January 2030||August 28, 2012||January 4, 2018||
† Study has passed its completion date and status has not been verified in more than two years.